ULBI (Ultralife Corporation) צמיחה צפויה ברווח נקי למניה השנה

Ultralife Corporation (ULBI) develops ruggedized lithium power systems for medical and military applications, maintaining its niche through patents and Pentagon certifications. Year-over-year changes in EPS reflect profit dynamics, where the value of 0.00 serves as the current metric. Revenues are based on US government contracts and raw material costs. The strategy relies on scaling production and expanding into the high-margin IT segment.
פילוחים אנליטיים ודוחות נתונים של חברת Ultralife Corp. (ULBI)

This metric measures the dynamics of earnings per share, reflecting the growth rate of capital efficiency over a twelve-month period. By analyzing the annual EPS growth profile, an investor assesses the ability of Ultralife Corporation (ULBI) to scale revenues, which in this case is supported by steady demand from the defense and medical sectors through long-term contracts.